Impact of magnetic resonance angiography parameters on stroke prevention therapy in pediatric patients with sickle cell anemia.
Kaitlin StrumphKerry A MorroneParmpreet DhillonKevin HsuWilliam GomesEllen SilverDaniel LaxQi PengSeon Kyu LeeDeepa ManwaniWilliam Beauregard MitchellPublished in: Pediatric blood & cancer (2022)
Optimizing flow artifact by decreasing echo time to less than 5 ms can improve accurate interpretation of cerebrovascular disease, and ensure appropriate treatment plans are in place for stroke prevention. This is especially important for implementing "TCD With Transfusions Changing to Hydroxyurea (TWiTCH)" clinical trial results in the real-world setting.
Keyphrases
- magnetic resonance
- clinical trial
- atrial fibrillation
- contrast enhanced
- computed tomography
- optical coherence tomography
- chronic kidney disease
- mass spectrometry
- multiple sclerosis
- ms ms
- high resolution
- stem cells
- open label
- magnetic resonance imaging
- cerebral ischemia
- quality improvement
- health insurance
- study protocol
- randomized controlled trial
- iron deficiency
- sickle cell disease
- diffusion weighted
- combination therapy
- blood brain barrier
- image quality
- dual energy
- smoking cessation